Taken together, these data indicate that the balance among PP2A, SET, and CIP2A may play a crucial role not only for maintenance of CML progenitors both in chronic and blastic phase but also for the population of leukemic stem cells showing innate resistance to TKI. The gene discussed is SET; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.